Mumbai (Maharashtra) [India], December 2: ImmunoAdoptive Cell Therapy (ImmunoACT), the Mumbai, India-based pioneering research and cell and gene therapy development company, announced a strategic partnership with Mango Sciences, Inc., the Boston, US, and Bengaluru, IN-based data and AI compa
The VMMC and Safdarjung Hospital has successfully performed its first-ever Chimeric Antigen Receptor T-cell (CAR-T) therapy under the leadership of Prof. Sandeep Bansal (Medical Superintendent), a novel treatment for certain types of lymphoma and blood cancers.
Despite the fact that chimeric antigen receptor T-cell (CAR-T) therapy has transformed cancer treatment, few studies have looked into its impact on long-term patient quality of life - an aspect of care that is frequently compromised when patients receive traditional intensive cancer medicati
Seoul [South Korea], October 21 (ANI/Global Economic): An anticancer treatment 'CAR-T (chimeric antigen receptor T-cell),' called a miracle anticancer drug, has been developed and the first clinical trial in Korea is being conducted.